Furthermore, we previously documented lower levels of HuR in peripheral blood mononuclear cells (PBMCs) from MS patients compared to healthy controls (HC), thus emphasizing the potential involvement of HuR in MS pathogenesis [36,37]. This evidence concerns the gene ELAVL1 and myeloid sarcoma.